Around 20-30% epileptic patients do not achieve seizure freedom despite well selected and tolerated pharmacological treatment. Surgery is a widely accepted treatment option for these patients. Factors influencing long term outcomes after elective surgical intervention remain poorly studied. One recent study (Lamberink et al., 2020) addressed this issue analysing the association between histopathology and seizure outcome and drug freedom up to 5 years after epilepsy surgery. In this retrospective, multicentre, longitudinal, cohort study, patients who had epilepsy surgery between Jan 1, 2000, and Dec 31, 2012, at 37 collaborating tertiary referral centres across 18 European countries of the European Epilepsy Brain Bank consortium were assessed.
Read more here